Clinical Trial Results:
A 12-WEEK, PHASE 4, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED,
PARALLEL GROUP, MULTICENTER TRIAL IN OVERACTIVE BLADDER SUBJECTS
TO CONFIRM THE EFFICACY OF 8 MG FESOTERODINE COMPARED TO 4 MG
FESOTERODINE
Summary
|
|
EudraCT number |
2010-024181-22 |
Trial protocol |
SE CZ HU DE FI GR LT AT DK SK BG NO GB IT |
Global completion date |
04 Nov 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jul 2016
|
First version publication date |
13 Feb 2015
|
Other versions |
|
Summary report(s) |
Public Disclosure Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.